SGMT Earnings Sagimet Biosciences Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.33 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -1.58 | 2026-03-11 | 10-K |
| Q3 2025 | 2025-09-30 | -1.28 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.89 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.56 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -1.45 | 2026-03-11 | 10-K |
| Q3 2025 | 2024-09-30 | -0.95 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.48 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.23 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -2.66 | 2025-03-12 | 10-K |
| Q3 2024 | 2023-09-30 | -3.22 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -71.39 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -35.58 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -165.20 | 2024-03-25 | 10-K |
| Q3 2023 | 2022-09-30 | -126.13 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -85.80 | 2023-08-21 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.